Hans-Peter Gerber

11.7k total citations · 6 hit papers
16 papers, 8.9k citations indexed

About

Hans-Peter Gerber is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Hans-Peter Gerber has authored 16 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Nephrology. Recurrent topics in Hans-Peter Gerber's work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Hans-Peter Gerber is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Hans-Peter Gerber collaborates with scholars based in United States, Canada and Switzerland. Hans-Peter Gerber's co-authors include Joe Kowalski, Napoleone Ferrara, Zena Werb, Thiennu H. Vu, Anne Ryan, Vishva M. Dixit, Minhong Yan, Bruce A. Keyt, N. Ferrara and Susan E. Quaggin and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Hans-Peter Gerber

16 papers receiving 8.7k citations

Hit Papers

Vascular Endothelial Growth Factor Regulates Endothelial ... 1998 2026 2007 2016 1998 1999 2003 2008 2003 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
    1998 1.7k citations Hans-Peter Gerber, Joe Kowalski et al. Journal of Biological Chemistry profile →
  2. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
    1999 1.6k citations Hans-Peter Gerber, Thiennu H. Vu et al. Nature Medicine profile →
  3. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
    2003 1.6k citations Thorsten Cramer, Yuji Yamanishi et al. Cell profile →
  4. VEGF Inhibition and Renal Thrombotic Microangiopathy
    2008 1.1k citations Vera Eremina, J. Ashley Jefferson et al. New England Journal of Medicine profile →
  5. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
    2003 1.0k citations Vera Eremina, Manish M. Sood et al. Journal of Clinical Investigation profile →
  6. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
    1998 513 citations N. Ferrara, Terri Davis-Smyth et al. Nature Medicine profile →

Peers

Hans-Peter Gerber
Joanne E. Murphy-Ullrich United States
Chuanyue Wu United States
Daniel F. Bowen‐Pope United States
Lucia R. Languino United States
David H. Lovett United States
Anton Jan van Zonneveld Netherlands
Jun‐ichi Hanai United States
Peter L. Weissberg United Kingdom
Alain Mauviel France
Matthias Clauss United States
Joanne E. Murphy-Ullrich United States
Hans-Peter Gerber
Citations per year, relative to Hans-Peter Gerber Hans-Peter Gerber (= 1×) peers Joanne E. Murphy-Ullrich

Countries citing papers authored by Hans-Peter Gerber

Since Specialization
Citations

This map shows the geographic impact of Hans-Peter Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Peter Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Peter Gerber more than expected).

Fields of papers citing papers by Hans-Peter Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Peter Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Peter Gerber. The network helps show where Hans-Peter Gerber may publish in the future.

Co-authorship network of co-authors of Hans-Peter Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Peter Gerber. A scholar is included among the top collaborators of Hans-Peter Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Peter Gerber. Hans-Peter Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wen, Miao, Abigail Yu, Young Joo Park, et al.. (2025). Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations. mAbs. 17(1). 2498162–2498162. 5 indexed citations
2.
Jin, Jing, Chengjin Li, Ruijun Tian, et al.. (2012). Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function. Cell. 151(2). 384–399. 117 indexed citations
3.
Oflazoglu, Ezogelin, Ivan J. Stone, Kristine A. Gordon, et al.. (2008). Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker. Clinical Cancer Research. 14(19). 6171–6180. 93 indexed citations
4.
Eremina, Vera, J. Ashley Jefferson, Jolanta Kowalewska, et al.. (2008). VEGF Inhibition and Renal Thrombotic Microangiopathy. New England Journal of Medicine. 358(11). 1129–1136. 1116 indexed citations breakdown →
5.
Cramer, Thorsten, Yuji Yamanishi, Björn E. Clausen, et al.. (2003). HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation. Cell. 112(5). 645–657. 1641 indexed citations breakdown →
6.
Lammert, Eckhard, Margaret McLaughlin, Dennis Brown, et al.. (2003). Role of VEGF-A in Vascularization of Pancreatic Islets. Current Biology. 13(12). 1070–1074. 309 indexed citations
7.
Gerber, Hans-Peter. (2003). Anti-angiogenesis: biology is the foundation for therapy. Drug Discovery Today. 8(8). 344–346. 8 indexed citations
8.
Blouw, Barbara, Tarık Tihan, Napoleone Ferrara, et al.. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 4(2). 133–146. 312 indexed citations
9.
Eremina, Vera, Manish M. Sood, Jody J. Haigh, et al.. (2003). Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. Journal of Clinical Investigation. 111(5). 707–716. 1011 indexed citations breakdown →
10.
Gerber, Hans-Peter, et al.. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Medicine. 5(6). 623–628. 1648 indexed citations breakdown →
11.
Giraudo, Enrico, Luca Primo, Enrica Audero, et al.. (1998). Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial Cells. Journal of Biological Chemistry. 273(34). 22128–22135. 242 indexed citations
12.
Gerber, Hans-Peter, Joe Kowalski, Minhong Yan, et al.. (1998). Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway. Journal of Biological Chemistry. 273(46). 30336–30343. 1670 indexed citations breakdown →
13.
Ferrara, N., Terri Davis-Smyth, Hans-Peter Gerber, et al.. (1998). Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Medicine. 4(3). 336–340. 513 indexed citations breakdown →
14.
Gerber, Hans-Peter, Michael Hagmann, Katja Seipel, et al.. (1995). RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature. 374(6523). 660–662. 138 indexed citations
15.
16.
Gerber, Hans-Peter, et al.. (1992). In vitrotranscription complementation assay with miniextracts of transiently transfected COS-1 cells. Nucleic Acids Research. 20(21). 5855–5856. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne E. Murphy-Ullrich Breakdown of academic impact, for papers by Chuanyue Wu Breakdown of academic impact, for papers by Daniel F. Bowen‐Pope Breakdown of academic impact, for papers by Lucia R. Languino Breakdown of academic impact, for papers by David H. Lovett Breakdown of academic impact, for papers by Anton Jan van Zonneveld Breakdown of academic impact, for papers by Jun‐ichi Hanai Breakdown of academic impact, for papers by Peter L. Weissberg Breakdown of academic impact, for papers by Alain Mauviel Breakdown of academic impact, for papers by Matthias Clauss
Rankless by CCL
2026